SFRP5 and metabolic dysfunction-associated steatotic liver disease: Clinical studies in adults suggest that Sfrp5 plays a prominent role in regulating adipogenesis, inflammation, glucose homeostasis, lipid metabolism, cardiovascular disease, non-alcoholic fatty-liver disease (NAFLD), and oxidative stress [14,15,16,17].